Notably, many of these miRNAs were also upregulated during granulocytopoiesis of normal CD34+ HPSs [40, 43] and they showed decreased expression levels in patients with AML [29, 33, 40, 41]. The gene discussed is CD34; the disease is acute myeloid leukemia.